SILVAPHL Share Price Performance
৳10.70
-4.50 (-29.61%)
Price ৳10.70
Share Price৳10.70
SILVAPHL Community Narratives
There are no narratives available yet.
Recent SILVAPHL News & Updates
No updates
Silva Pharmaceuticals Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.96
- Gross Margin
- 26.67%
- Net Profit Margin
- -30.48%
- Debt/Equity Ratio
- 1.7%
Silva Pharmaceuticals Limited Competitors
About SILVAPHL
- Founded
- 2001
- Employees
- 688
- CEO
- WebsiteView website
Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, anti histamine, anti spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in various therapeutic area, such as anemias and other blood disorders, central nervous system, anti infectives, respiratory system, cardiovascular system, endocrine system, and natural sweetener; agrovet and pesticides products; and herbal and nutraceuticals products comprising anti-tussive and expectorant, hepato-protective, CNS and antidepressant, adaptogen and Immuno modulator, hematinic, gastrointestinal, and hormonal products. Silva Pharmaceuticals Limited was incorporated in 2001 and is headquartered in Dhaka, Bangladesh.
Bangladeshi Market Performance
- 7 Days: 2.7%
- 3 Months: 10.4%
- 1 Year: 5.1%
- Year to Date: 2.9%
The market is up 2.7% over the last week, with the Financials sector leading the way, up 2.8%. As for the past 12 months, the market is up 5.1%. Earnings are forecast to grow by 16% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading